- Home
- SPAI vs AADI Comparison
SPAI vs AADI Comparison
Compare SPAI & AADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- AADI
- Stock Information
- Founded
- SPAI 2021
- AADI 2011
- Country
- SPAI United States
- AADI United States
- Employees
- SPAI N/A
- AADI N/A
- Industry
- SPAI Industrial Specialties
- AADI Biotechnology: Pharmaceutical Preparations
- Sector
- SPAI Health Care
- AADI Health Care
- Exchange
- SPAI Nasdaq
- AADI Nasdaq
- Market Cap
- SPAI 61.4M
- AADI 59.4M
- IPO Year
- SPAI 2024
- AADI N/A
- Fundamental
- Price
- SPAI $3.57
- AADI $3.04
- Analyst Decision
- SPAI
- AADI Hold
- Analyst Count
- SPAI 0
- AADI 3
- Target Price
- SPAI N/A
- AADI $1.75
- AVG Volume (30 Days)
- SPAI 696.1K
- AADI 615.0K
- Earning Date
- SPAI 11-14-2024
- AADI 11-06-2024
- Dividend Yield
- SPAI N/A
- AADI N/A
- EPS Growth
- SPAI N/A
- AADI N/A
- EPS
- SPAI N/A
- AADI N/A
- Revenue
- SPAI $1,559,057.00
- AADI $25,070,000.00
- Revenue This Year
- SPAI N/A
- AADI $10.15
- Revenue Next Year
- SPAI N/A
- AADI $5.32
- P/E Ratio
- SPAI N/A
- AADI N/A
- Revenue Growth
- SPAI 35.50
- AADI 7.80
- 52 Week Low
- SPAI $1.56
- AADI $1.21
- 52 Week High
- SPAI $6.50
- AADI $3.60
- Technical
- Relative Strength Index (RSI)
- SPAI N/A
- AADI 74.24
- Support Level
- SPAI N/A
- AADI $2.07
- Resistance Level
- SPAI N/A
- AADI $3.60
- Average True Range (ATR)
- SPAI 0.00
- AADI 0.22
- MACD
- SPAI 0.00
- AADI 0.07
- Stochastic Oscillator
- SPAI 0.00
- AADI 74.51
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Safe-Pro USA.
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.